| Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing LM Lim, N Ly, D Anderson, JC Yang, L Macander, A Jarkowski III, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (12 …, 2010 | 556 | 2010 |
| Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations CB Landersdorfer, JB Bulitta, M Kinzig, U Holzgrabe, F Sörgel Clinical pharmacokinetics 48, 89-124, 2009 | 343 | 2009 |
| Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model PJ Bergen, JB Bulitta, A Forrest, BT Tsuji, J Li, RL Nation Antimicrobial agents and chemotherapy 54 (9), 3783-3789, 2010 | 209 | 2010 |
| Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial SG Sakka, AK Glauner, JB Bulitta, M Kinzig-Schippers, W Pfister, ... Antimicrobial agents and chemotherapy 51 (9), 3304-3310, 2007 | 190 | 2007 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria AP Zavascki, JB Bulitta, CB Landersdorfer Expert review of anti-infective therapy 11 (12), 1333-1353, 2013 | 188 | 2013 |
| Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at … PJ Bergen, A Forrest, JB Bulitta, BT Tsuji, HE Sidjabat, DL Paterson, J Li, ... Antimicrobial agents and chemotherapy 55 (11), 5134-5142, 2011 | 150 | 2011 |
| Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population … JB Bulitta, JC Yang, L Yohonn, NS Ly, SV Brown, RE D'Hondt, WJ Jusko, ... Antimicrobial agents and chemotherapy 54 (5), 2051-2062, 2010 | 150 | 2010 |
| Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model PJ Bergen, BT Tsuji, JB Bulitta, A Forrest, J Jacob, HE Sidjabat, ... Antimicrobial agents and chemotherapy 55 (12), 5685-5695, 2011 | 149 | 2011 |
| Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans JB Bulitta, WW Hope, AE Eakin, T Guina, VH Tam, A Louie, GL Drusano, ... Antimicrobial agents and chemotherapy 63 (5), 10.1128/aac. 02307-18, 2019 | 146 | 2019 |
| Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients … P Prokocimer, P Bien, J Surber, P Mehra, C DeAnda, JB Bulitta, GR Corey Antimicrobial agents and chemotherapy 55 (2), 583-592, 2011 | 135 | 2011 |
| Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers MWR Pletz, M Rau, J Bulitta, A De Roux, O Burkhardt, G Kruse, ... Antimicrobial agents and chemotherapy 48 (10), 3765-3772, 2004 | 133 | 2004 |
| Development of a new pre-and post-processing tool (SADAPT-TRAN) for nonlinear mixed-effects modeling in S-ADAPT JB Bulitta, A Bingölbali, BS Shin, CB Landersdorfer The AAPS journal 13, 201-211, 2011 | 130 | 2011 |
| The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections T Tängdén, V Ramos Martín, TW Felton, EI Nielsen, S Marchand, ... Intensive care medicine 43, 1021-1032, 2017 | 128 | 2017 |
| Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers JB Bulitta, SB Duffull, M Kinzig-Schippers, U Holzgrabe, U Stephan, ... Antimicrobial agents and chemotherapy 51 (7), 2497-2507, 2007 | 128 | 2007 |
| Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers WA Krueger, J Bulitta, M Kinzig-Schippers, C Landersdorfer, U Holzgrabe, ... Antimicrobial agents and chemotherapy 49 (5), 1881-1889, 2005 | 127 | 2005 |
| Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units JF Roos, J Bulitta, J Lipman, CMJ Kirkpatrick Journal of Antimicrobial Chemotherapy 58 (5), 987-993, 2006 | 120 | 2006 |
| Clinical population pharmacokinetics and toxicodynamics of linezolid LM Boak, CR Rayner, ML Grayson, DL Paterson, D Spelman, S Khumra, ... Antimicrobial agents and chemotherapy 58 (4), 2334-2343, 2014 | 118 | 2014 |
| The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic … ZZ Deris, HH Yu, K Davis, RL Soon, J Jacob, CK Ku, A Poudyal, ... Antimicrobial agents and chemotherapy 56 (10), 5103-5112, 2012 | 118 | 2012 |
| Effects of grapefruit juice on the pharmacokinetics of sildenafil A Jetter, M Kinzig‐Schippers, M Walchner‐Bonjean, U Hering, J Bulitta, ... Clinical Pharmacology & Therapeutics 71 (1), 21-29, 2002 | 115 | 2002 |
| Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic … HJ Lee, PJ Bergen, JB Bulitta, B Tsuji, A Forrest, RL Nation, J Li Antimicrobial agents and chemotherapy 57 (8), 3738-3745, 2013 | 114 | 2013 |
